The pharmacological antagonists of NK-1R have been used so far for treating diverse conditions, such as mood disorders (depression, anxiety and stress), nausea associated with chemotherapy, rheumatoid arthritis, and inflammatory bowel disease [32, 33]. The gene discussed is TACR1; the disease is depressive disorder.